39
Participants
Start Date
July 31, 2006
Study Completion Date
December 31, 2006
Midazolam
The study drug was administered IM into the anterior thigh using the preloaded autoinjector. The autoinjectors were preloaded with midazolam 5 mg or 10 mg with a total volume of 1 or 2 mL. Healthy subjects were assigned to one of six target dosage groups (0.10, 0.18, 0.25, 0.33, 0.40, 0.49 mg/kg) and, based on their weight, received the necessary combination of fixed 5 or 10 mg doses to provide the assigned target dose.
BASi Baltimore Clinical Research Unit, Baltimore
U.S. Army Office of the Surgeon General
FED